|Articles|September 1, 2017
- Pharmaceutical Executive-09-01-2017
- Volume 37
- Issue 9
Pharmaceutical Executive, September 2017 Issue (PDF)
Click the title above to open the Pharmaceutical Executive September 2017 issue in an interactive PDF format.
Advertisement
Articles in this issue
almost 9 years ago
Pharm Exec's 16th Annual Industry Auditalmost 9 years ago
The Supply Chain: What Price Patient Centricity?almost 9 years ago
Drug Serialization for DSCSA Compliance Benefits Everyonealmost 9 years ago
Pharm Exec's 16th Annual Industry Audit (Overview)almost 9 years ago
You Are Pharmaalmost 9 years ago
Leading With Patients in Mind: Cynthia Schwalmalmost 9 years ago
FDA, Industry Prepare for New User Fee Initiativesalmost 9 years ago
Data Inflection Pointalmost 9 years ago
UK Unveils Post-Brexit Life Sciences Strategyalmost 9 years ago
Seizing the Opportunity in STEMAdvertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on PharmExec
1
FDA Approves Lipfendra to reduce LDL-C in Adults with Hypercholesterolemia
2
Jasper Therapeutics to Acquire Kira Pharmaceuticals in $132 Million Merger Agreement
3
Pharmaceutical Executive Daily: FDA Approves Lipfendra
4
From Dr. Google to Dr. Claude: Why the Most Important Patient Support Innovation Is Still Human Connection
5